Humana Inc. (NYSE:HUM) Shares Sold by Amalgamated Bank

Amalgamated Bank reduced its holdings in shares of Humana Inc. (NYSE:HUM) by 3.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 31,591 shares of the insurance provider’s stock after selling 1,201 shares during the quarter. Amalgamated Bank’s holdings in Humana were worth $14,463,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Rakuten Securities Inc. purchased a new position in Humana in the fourth quarter valued at approximately $25,000. Gradient Investments LLC increased its position in shares of Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 40 shares in the last quarter. Cetera Trust Company N.A purchased a new stake in shares of Humana in the 4th quarter valued at about $28,000. Nvwm LLC boosted its position in shares of Humana by 41.0% in the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after purchasing an additional 25 shares during the period. Finally, Turtle Creek Wealth Advisors LLC purchased a new position in Humana during the 4th quarter worth approximately $55,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Insider Buying and Selling at Humana

In related news, Director Jorge S. Mesquita acquired 545 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was purchased at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the transaction, the director now directly owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 0.32% of the company’s stock.

Analysts Set New Price Targets

HUM has been the subject of a number of research reports. Raymond James began coverage on Humana in a research note on Friday, March 22nd. They issued a “market perform” rating for the company. TheStreet downgraded shares of Humana from a “b” rating to a “c+” rating in a research report on Monday, January 8th. Stephens reduced their target price on shares of Humana from $550.00 to $430.00 and set an “overweight” rating for the company in a report on Friday, January 26th. Barclays decreased their target price on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 2nd. Finally, Wells Fargo & Company dropped their price target on Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Eleven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $424.50.

Humana Price Performance

Shares of NYSE:HUM traded down $0.38 during trading on Friday, hitting $320.60. 1,802,627 shares of the stock were exchanged, compared to its average volume of 1,992,055. Humana Inc. has a 12-month low of $298.61 and a 12-month high of $541.21. The company has a market cap of $38.63 billion, a PE ratio of 19.96, a P/E/G ratio of 1.83 and a beta of 0.49. The company has a fifty day moving average price of $324.67 and a two-hundred day moving average price of $389.56. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.12 by $1.11. The company had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. Humana’s revenue was up 10.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $9.38 earnings per share. On average, analysts forecast that Humana Inc. will post 16.18 EPS for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.10%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s payout ratio is currently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.